Acurx Pharmaceuticals, Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-27.
Acurx Pharmaceuticals, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 27, 2025. The filing reports $3.98M sold. Its industry group is Pharmaceuticals. It names DAVID LUCI (CHIEF EXECUTIVE OFFICER), ROBERT DELUCCIA (EXECUTIVE CHAIRMAN), ROBERT SHAWAH (CHIEF FINANCIAL OFFICER) (SEC Form D, June 27, 2025).
Is this your company?
Sell to companies like Acurx Pharmaceuticals, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-27 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Acurx Pharmaceuticals, Inc.
Free to see. No signup.
More on the people and the money behind Acurx Pharmaceuticals, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in New York, filed within 90 days of this one, largest first.
Get an email when Acurx Pharmaceuticals, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Acurx Pharmaceuticals, Inc. raises, hires or launches. No email unless you switch it on.
Watch Acurx Pharmaceuticals, Inc. →Get the full cited report on Acurx Pharmaceuticals, Inc.
What the filing shows about Acurx Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Acurx Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Acurx Pharmaceuticals, Inc.'s address as 259 Liberty Avenue, Staten Island, NY 10305.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Acurx Pharmaceuticals, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Acurx Pharmaceuticals, Inc. See pricing
Acurx Pharmaceuticals, Inc. is a registered filer with the SEC (CIK 1736243) and has filed since 2025-01-17. 5 filings are on record, the latest on 2026-04-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Acurx Pharmaceuticals, Inc.'s Form D of 2025-06-27 names DAVID LUCI, ROBERT DELUCCIA, ROBERT SHAWAH and 5 more as its officers, directors or promoters.
Its new offerings report $14.35M sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
On the filing as: Executive Officer, Director.
David Luci is named as Chief Executive Officer on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 27 June 2025, one of 8 people that filing names.
On the filing as: Executive Officer, Director.
Robert Deluccia is named as Executive Chairman on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 27 June 2025, one of 8 people that filing names.
On the filing as: Executive Officer.
Robert Shawah is named as Chief Financial Officer on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 27 June 2025, one of 8 people that filing names.
Jack Dean is named as Director on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 27 June 2025, one of 8 people that filing names.
James Donohue is named as Director on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 27 June 2025, one of 8 people that filing names.
Thomas Harrison is named as Director on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 27 June 2025, one of 8 people that filing names.
Carl Sailer is named as Director on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 27 June 2025, one of 8 people that filing names.
Joseph Scodari is named as Director on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 27 June 2025, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role and 5 as directors only.
Named as of the 2025-06-27 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Acurx Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Acurx Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Acurx Pharmaceuticals, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Acurx Pharmaceuticals, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Acurx Pharmaceuticals, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Acurx Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in New York
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/acurx-pharmaceuticals-inc-form-d-25000001